A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Trial Identifier: D8540C00002
Sponsor: MedImmune, LLC
NCTID:: NCT03811652
Start Date: December 2018
Primary Completion Date: December 2019
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
French Translation

Trial Locations

Country Location
Canada, ON Toronto, ON, Canada, M5G 2M9
United States of America, NC Huntersville, NC, United States of America, 28078
United States of America, TN Nashville, TN, United States of America, 37203